Focused on the cell therapy manufacturing bottleneck, Cellares turbocharges plans for ‘shuttle’ tech

When Cellares CEO and co-founder Fabian Gerlinghaus tore his ACL a few years ago, he was brought outside of a Bay Area hospital to the parking lot where he received an MRI inside a truck. He and his colleagues hope that the same can be done for cell therapy —...

Click to view original post